| # | Drug | Count |
|---|---|---|
| 0 | DOXORUBICIN | 7 |
| 1 | METHOTREXATE | 5 |
| 2 | METHOTREXATE SODIUM | 5 |
| 3 | PAZOPANIB HYDROCHLORIDE | 5 |
| 4 | PREDNISONE | 5 |
| 5 | ACETAMINOPHEN | 4 |
| 6 | ACETAMINOPHEN 500MG | 4 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 4 |
| 8 | ALLOPURINOL | 4 |
| 9 | BENDAMUSTINE HYDROCHLORIDE | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACTINOMYCIN | 2 | 0.0009 |
| 1 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 2 | BENDAMUSTINE HYDROCHLORIDE | 4 | 0.0005 |
| 3 | TREMELIMUMAB | 2 | 0.0005 |
| 4 | PAZOPANIB HYDROCHLORIDE | 5 | 0.0002 |
| 5 | IFOSFAMIDE FOR INJECTION | 3 | 0.0001 |
| 6 | DACARBAZINE | 1 | 0.0001 |
| 7 | BLEOMYCIN SULFATE | 1 | 0.0001 |
| 8 | DURVALUMAB | 2 | 0.0001 |
| 9 | VELPATASVIR AND SOFOSBUVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 2 | 0.0009 |
| 1 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 3 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 4 | 0.0000 |
| 6 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 4 | 0.0000 |